News
Israeli medical cannabis company planning early Malta expansion
July 29, 2022
July 29, 2022 | The Malta Independent An Israeli medical cannabis company, Panaxia, has announced a €6 million investment and is set to deepen its connection with
Panaxia announces production license of medical cannabis products in Malta
May 19, 2022
May 19, 2022 | Yahoo! Finance Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the
Panaxia sums up 2021 with a growth of 38% in total revenues of its Israeli activity, including initial revenues from cannabis oils export of 5.6 million
April 5, 2022
April 5, 2022 | BENZINGA – Net Israeli revenues in 2021 increased 38% to 83.6 million. – Initial revenues from medical cannabis oils export from Israel, which
Panaxia’s Malta Facility Granted EU-GMP Standard, Enabling Export Of Its Products Across Various EU Countries
January 3, 2022
January 3, 2022 | BENZINGA Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard